On June 9, 2022 Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, reported that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the Jefferies Global Healthcare Conference (Press release, Aldeyra Therapeutics, JUN 9, 2022, View Source [SID1234615837]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Brady’s conversation with Kelly Shi, Ph.D., Senior Vice President, Senior Research Analyst in Biotechnology for Jefferies, is scheduled to begin at 9:30 a.m. ET Friday, June 10, 2022. To view the live webcast, log in to the Investors & Media section of the Aldeyra website at View Source A video replay will be available following the live fireside chat and will be archived on the website for 90 days.